Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence

Sponsor
University of Virginia (Other)
Overall Status
Completed
CT.gov ID
NCT01528748
Collaborator
(none)
8
1
87
0.1

Study Details

Study Description

Brief Summary

This study examines the effectiveness of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) in reducing both alcohol consumption and depressive symptoms in adults who are chronically depressed and alcohol dependent.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Analysis System of Psychotherapy

Detailed Description

This study examines the effectiveness of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) in reducing both alcohol consumption and depressive symptoms in adults who are chronically depressed and alcohol dependent. Participants will receive a 20-session course of CBASP psychotherapy over a period of 21 weeks and will be assessed for severity of pretreatment psychological abuse and trauma as well as pre and posttreatment interpersonal functioning. Two primary hypotheses are to be tested: 1) demonstrate that CBASP is effective in reducing depressive symptoms (Hamilton Rating Scale for Depression-24 ratings) and alcohol consumption (drinks per drinking day) in this chronically depressed alcohol dependent cohort when posttreatment ratings are compared to pretreatment levels; and 2) demonstrate that acquisition of feeling safe with the therapist and acquisition of the ability to perceive the interpersonal consequences of one's behavior will significantly increase from pre to posttreatment levels and will be associated with reductions in drinking and depressive symptoms.

Study Design

Study Type:
Observational
Actual Enrollment :
8 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence
Study Start Date :
Apr 1, 2011
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Chronically Depressed, Alcohol Dependent

Participants who have been formally diagnosed with a clinical diagnosis of Chronic Depression and Alcohol Dependence.

Behavioral: Cognitive Behavioral Analysis System of Psychotherapy
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a behavioral intervention that addresses the unique behavioral characteristics of chronically depressed individuals, most of which are highly relevant for alcoholics as well. CBASP has a structured, individualized, and collaborative (patient and clinician) design. The intervention emphasizes teaching effective coping strategies and employing motivational, cognitive, behavioral, and interpersonal techniques. Individual therapy (1 hour) sessions occur on a weekly basis for a total of 20 sessions over a period of 21 weeks.
Other Names:
  • CBASP
  • Outcome Measures

    Primary Outcome Measures

    1. Depression Rating [Baseline and 20 weeks]

      Change in depression rating scale over time.

    2. Drinking behavior [Baseline and 20 weeks]

      Change in number of drinks consumed per day over time.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis of a current major depressive disorder (e.g., Major Depression, Dysthymic Disorder) for a minimum of two years

    • Clinical diagnosis of alcohol dependence during the last thirty days

    • Interest in changing one's drinking and alleviating depressive symptoms

    Exclusion Criteria:
    • Please call study site for additional information

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Virginia Center for Addiction Research & Education (UVa CARE) Charlottesville Virginia United States 22911

    Sponsors and Collaborators

    • University of Virginia

    Investigators

    • Principal Investigator: Jennifer K. Penberthy, Ph.D., University of Virginia, School of Medicine, Department of Psychiatry & Neurobehavioral Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jennifer Kim Penberthy, Associate Professor, School of Medicine, University of Virginia
    ClinicalTrials.gov Identifier:
    NCT01528748
    Other Study ID Numbers:
    • 15599
    First Posted:
    Feb 8, 2012
    Last Update Posted:
    Apr 17, 2019
    Last Verified:
    Apr 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 17, 2019